Botanical species · safety record

Eclipta prostrata

The EFSA Compendium of Botanicals holds 1 constituent measurement for Eclipta prostrata. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Eclipta prostrata (L.) L.

1Constituent measurements
0Safety records
1Cited sources
142Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 142 licensed products naming Eclipta prostrata as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA

Source material stated

  • Aerial parts
  • Dried aerial part(s)
  • Eclipta prostrata
  • Flower
  • Herb
  • Herb top
  • Leaf
  • Root

What the records describe

Constituents measured

  • Wedelolactone1

Plant parts

  • Unspecified1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
WedelolactoneUnspecifiedUnspecifiedResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Xia, Yanzhe., Chen, Jie., Cao, Yuan., Xu, Chenshu., Li, Ruiming., Pan, Yuhua., Chen, Xiao. Wedelolactone exhibits anti-fibrotic effects on human hepatic stellate cell line LX-2 . European journal of pharmacology, 2013, vol. 714, no. 1-3, p. 105-111. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue